Skip to main content
PMC home page
Taylor & Francis Open Select logoLink to Taylor & Francis Open Select
. 2008 Dec 4;43(1):4–12. doi: 10.1080/10715760802582183

Antioxidant properties of MitoTEMPOL and its hydroxylamine

Jan Trnka 1, Frances H Blaikie 2, Angela Logan 1, Robin A J Smith 2, Michael P Murphy 1
PMCID: PMC2645131  PMID: 19058062

Abstract

Piperidine nitroxides such as TEMPOL have been widely used as antioxidants in vitro and in vivo. MitoTEMPOL is a mitochondria-targeted derivative of TEMPOL designed to protect mitochondria from the oxidative damage that they accumulate, but once there is rapidly reduced to its hydroxylamine, MitoTEMPOL-H. As little is known about the antioxidant efficacy of hydroxylamines, this study has assessed the antioxidant activity of both MitoTEMPOL and MitoTEMPOL-H. The hydroxylamine was more effective at preventing lipid-peroxidation than MitoTEMPOL and decreased oxidative damage to mitochondrial DNA caused by menadione. In contrast to MitoTEMPOL, MitoTEMPOL-H has no superoxide dismutase activity and its antioxidant actions are likely to be mediated by hydrogen atom donation. Therefore, even though MitoTEMPOL is rapidly reduced to MitoTEMPOL-H in cells, it remains an effective antioxidant. Furthermore, as TEMPOL is also reduced to a hydroxylamine in vivo, many of its antioxidant effects may also be mediated by its hydroxylamine.

Keywords: MitoTEMPOL, nitroxide, hydroxylamine, lipid peroxidation, mtDNA, antioxidant

Introduction

Piperidine nitroxides such as TEMPOL (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxy radical; Figure 1) exhibit potent antioxidant effects in a variety of systems [1–9]. These properties have been ascribed to the ability of these nitroxides to catalyse the dismutation of superoxide [10,11], to detoxify redox-reactive forms of transition metal ions (ferrous, cuprous, ferryl) [12–14] and to react directly with many radicals, forming adducts with varying stabilities and breakdown chemistries [15,16].

Figure 1.

Figure 1

Open in a new tab

Structures of TEMPOL and MitoTEMPOL.

As mitochondria produce significant amounts of reactive oxygen species (ROS) and oxidative damage to mitochondria contributes to a number of pathologies [17], we synthesized a mitochondria targeted TEMPOL derivative called MitoTEMPOL (2,2,6,6-tetramethyl-4-[5-(triphenylphosphonio) pentoxy]piper-idin-1-oxy bromide) [18] (Figure 1). MitoTEMPOL comprises the piperidine nitroxide TEMPOL unit conjugated with a triphenylphosphonium (TPP) moiety [18]. As expected [19,20], the lipophilic TPP cation moiety enabled MitoTEMPOL to rapidly traverse biological membranes, accumulate several-hundred-fold in energized mitochondria and increased its affinity for adsorption to phospholipid bilayers [18]. The intention was that this selective targeting of TEMPOL to mitochondria would render MitoTEMPOL a more effective antioxidant, as has been done by targeting other antioxidants to mitochondria [20]. Intriguingly, we found that MitoTEMPOL was rapidly and completely reduced to its hydroxylamine MitoTEMPOL-H within respiring mitochondria by ubiquinol in the inner membrane [18]. Reduction of cyclic nitroxides in biological systems had been known for several decades [21,22], but the extent, site of reduction and the identity of the reductant had remained conjectural. For MitoTEMPOL this reduction is so extensive that the nitroxide cannot be detected in respiring mitochondria, suggesting that any antioxidant activity of MitoTEMPOL within mitochondria would be due to its hydroxyla-mine, MitoTEMPOL-H [18]. Hydroxylamines, including those derived from piperidine nitroxides [15,23–25] as well as tert-butylhydroxylamine [26,27], have antioxidant properties, however, the mechanism of these effects has not been studied in detail. Therefore here we have determined the anti-oxidant activity of MitoTEMPOL and MitoTEMPOL-H in order to assess whether targeting MitoTEMPOL to mitochondria remains a viable antioxidant strategy. We found that MitoTEMPOL-H was effective at preventing lipid peroxidation and at preventing mitochondrial DNA (mtDNA) damage, while the antioxidant activity of MitoTEMPOL was similar to that of TEMPOL. Therefore, targeting nitroxides to mitochondria is a valid antioxidant strategy, as the hydroxylamine is a potent antioxidant.

Materials and methods

Chemicals

MitoTEMPOL and MitoQ were prepared as previously described [18,28]. TEMPOL was from Aldrich, UK, propylTPP from Sigma, UK C11-BODIPY was from Molecular Probes, OR, USA. To reduce MitoTEMPOL to the hydroxylamine, MitoTEMPOL-H, MitoTEMPOL (10 μL of a 0.5 M solution in ethanol) was mixed with 10 μL of 0.5 M sodium ascorbate (pH∼6), reacted for ∼ 1 min at room temperature, during which time the colour changed from orange to pale yellow [29]. The reaction mixture was then diluted with 1 mL water and extracted into 1 mL CH2Cl2. The lower, organic phase was then removed, evaporated and the white residue was dissolved in water. The product was 98% MitoTEMPOL hydroxylamine (MitoTEMPOL-H), based on 1H-NMR comparison with phenylhydrazine-reduced samples. MitoTEMPOL-H slowly becomes oxidized in aerated solutions and therefore aliquots were stored in aqueous solution under an inert atmosphere at −20°C.

Preparation of mitochondria

Rat liver mitochondria were prepared by homogenization followed by differential centrifugation in 250 mM sucrose, 5 mM Tris-HCl, 1 mM EGTA, pH 7.4 [30]. Protein concentration was determined by the biuret assay using bovine serum albumin (BSA) as a standard [31]. Bovine heart mitochondrial membranes were prepared by disruption of bovine heart mitochondria in a blender followed by collection of the membranes by centrifugation [32,33].

Preparation of phospholipid vesicles

Small unilamellar phosphatidylcholine vesicles (SUV) were prepared as described [34]. Egg yolk phosphatidylcholine (5 mg) was dissolved in 100 ml chloroform, pipetted to a glass tube and evaporated to dryness overnight under a stream of N2. To the residue 5 ml of 50 mM Tris-Cl buffer (pH 7) was added and the lipid was left to hydrate for 1 h on a roller. The mixture was then vortexed vigorously and placed in a Decon F5 Minor sonicating water bath for ∼ 30 min at room temperature. The SUVs had a mean external spherical diameter of 86 ± 26 nm (n = 35, ± SD) [34].

Cell culture

C2C12 cells (murine myoblast-like cell line, from ECACC) were grown in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% (v/v) foetal calf serum, 100 U/ml penicillin and 100 μg/ml streptomycin at 37°C in a humidified atmosphere of 95% air/5% CO2. The cells were always passaged before reaching confluence and were used only up to passage number 10.

Assays

The concentration of ferrous iron was measured by the Ferrozine assay [35]. A sample of the reaction mixture (100 μl) was added to 900 μl of 1 mM Ferrozine in water, rapidly mixed and left to react for 10 ∼ min. The absorbance of the complex was measured at 562 nm and quanitified using an extinction coefficient at 562 nm of 27 900 M−1cm−1 [36]. All experiments studying the oxidation of ferrous iron by nitroxides were performed under an inert atmosphere (Ar) to prevent oxidation of the ferrous-EDTA complex by oxygen.

Superoxide dismutation was measured by the cytochrome c-superoxide assay. Superoxide was produced by the reaction of xanthine oxidase (20 mU/ml) with acetaldehyde (10 mM) in 50 mM potassium phosphate buffer (pH 8) supplemented with 500 μg/ml ferricytochrome c (from bovine heart, Sigma) at 30°C. The reduction of cytochrome c was measured at 550 nm using a Shimadzu UV-2501PC spectrophotometer. The effect of various compounds on superoxide dismutation was expressed as a percentage of the slope of cytochrome c reduction after the addition, relative to the slope before the addition. We tested whether MitoTEMPOL might affect cytochrome c reduction artifactually by inhibiting the activity of xanthine oxidase by using a fluorometric xanthine oxidase assay in which the non-fluorescent substrate pterine is converted by xanthine oxidase to isoxanthopterine, which fluoresces at λEx = 345 nm, λEm = 390 nm [37]. To a solution of pterine (20 μM) in 50 mM potassium phosphate buffer (pH 8) was added 20 mU/ml xanthine oxidase ± 100 mM MitoTEMPOL and, when the fluorescence increase was measured, no difference in the activity of xanthine oxidase with or without MitoTEMPOL was found (data not shown).

Oxidation of SUVs by peroxyl radicals derived from the decomposition of 2,2′-azobis(2-amidinopro-pane) (AAPH) was measured using C11-BODIPY(581/591) (Molecular Probes) [38]. SUVs (1 mg/ml) suspended in 50 mM Tris-Cl buffer (pH 7) (see above) were transferred to a quartz 3 ml cuvette and placed in a Shimadzu RF-5301PC fluorimeter thermostatted at 38°C with stirring. The vesicles were pre-incubated for 10 min with 200 nM C11-BODIPY to allow their incorporation into the lipid phase. After the addition of AAPH (25 mM) the decay of red fluorescence was followed at λEx = 540 nm, λEm = 590 nm.

Lipid peroxidation by hydrogen peroxide in bovine heart mitochondrial membranes (BHM) was measured by the thiobarbituric acid-reactive species (TBARS) assay [39]. BHM (1 mg protein) were suspended in 800 μl 50 mM potassium phosphate buffer (pH 8) supplemented with 25 mM glucose, 1 U/ml glucose oxidase (GO, from Aspergillus niger)± compounds to be tested. The samples from these incubations were then mixed with 0.1% di-tert-butylhydroxytoluene (2% (w/v) solution in DMSO), 200 μl of 1% (w/v) thiobarbituric acid and 200 μl of 35% (v/v) HClO4, heated at 100°C for 15 min, diluted with 2 ml of water and extracted once into 2 ml of n-butanol. Quintuplicate 200 μl aliquots of the butanol phase were transferred into a 96-well plate and TBARS were determined fluorometrically (λEx = 515 nm, λEm = 553 nm) in a Molecular Devices Spectra Max Gemini XS fluorometric plate reader. A standard curve of malondialdehyde (MDA) was prepared using serial dilutions of a 10 mM solution of 1,1,3,3-tetraethoxypropane hydrolysed overnight in 1% (v/v) sulphuric acid at 4°C.

EPR measurements

All spectra were acquired at room temperature (∼23–25°C) in a Bruker EMX spectrometer using the standard high-sensitivity resonator cavity ER 4102ST and a 300 μL quartz flat cell. Spectra were batch-analysed using a Perl script written by JT for this purpose. Quantitative results were expressed as the height of the low-field peak of the nitroxide spectrum [40].

Quantitative PCR (QPCR) assay

Damage to mitochondrial DNA (mtDNA) was measured by the quantitative PCR method [41]. C2C12 cells were seeded onto 6-well plates at 200 000 cells/well in culture medium and incubated overnight to adhere. Various concentrations of nitroxides or other compounds were then added and the cells were incubated for 1 h. Thereafter 25 μM menadione was added and cells were incubated for a further 1 h. The medium was then removed from the wells and cells were washed with 1 ml ice-cold phosphate-buffered saline (PBS) and harvested by scraping into 0.5 ml ice-cold PBS. Cells were then pelleted by centrifugation at 16 000 × g for 3 min in a benchtop centrifuge. The pellet was re-suspended in 200 μl cold PBS. Total cellular DNA was isolated using a DNeasy Blood & Tissue Kit from Qiagen according to the manufacturer's instructions with minor modifications. Cells were lysed by the addition of 200 μl proprietary lysis buffer. A solution of proteinase K was added (20 μl) and the lysate was incubated for 10 min at 70°C. Ethanol (210 μl) was then added and the lysate was transferred into DNA isolation columns, which were then centrifuged at 16 000 × g for 1 min and then sequentially washed with the two proprietary washing buffers. DNA was then eluted with 3 × 40 ml of elution buffer pre-heated to 70°C. Isolated DNA was then quantified fluorometrically using the PicoGreen assay (Molecular Probes) and stored in TE buffer at −20°C. The DNA was then diluted to a final concentration of 3 ng/μl, which was used as a template for PCR. The total volume for each PCR reaction was 50 μl, consisting of 15 ng DNA template, 35 μl PCR mastermix and 1 U rTth DNA polymerase XL (Applied Biosystems). The mastermix consisted of 5 μg BSA, 200 μM dNTP, 20 pmol forward primer, 20 pmol reverse primer and 1.0 mM magnesium acetate and was made up to 35 μl with nuclease-free water. The magnesium concentration was decreased to 0.9 mM for the short mitochondrial target. The primers for murine mtDNA were synthesized by Sigma-Genosys. Their sequences are:

  • Short target: 5′-GCC AGC CTG ACC CAT AGC CAT AAT-3′ 5′-GCC GGC TGC GTA TTC TAC GTT A-3′

  • Long target: 5′-GCC AGC CTG ACC CAT AGC CAT AAT-3′ 5′-GAG AGA TTT TAT GGG TGT AAT GCG G-3′

The PCR was begun with a manual hot-start: the mastermix and template were heated to 75°C, after which the polymerase was added. The parameters for the short mitochondrial target were 23 cycles of 30 s at 94°C, 45 s at 64°C, 45 s at 72°C, followed by 10 min at 72°C. The parameters for the long mitochondrial target were 1 min at 94°C, then 16 cycles of 15 s at 94°C, 12 min at 64°C, followed by a final extension step of 10 min at 72°C. The amplified DNA was then quantified using the PicoGreen assay (Molecular Probes) and the results expressed as amplification relative to the control (cells with no additions).

Statistics

All data were analysed using unpaired two-tailed Student's t-test in Microsoft Excel for Mac.

Results

Superoxide dismutase activity of MitoTEMPOL and MitoTEMPOL-H

Since piperidine nitroxides are known to be super-oxide dismutase (SOD)-mimetics we examined whether superoxide dismutation by TEMPOL was altered by adding an alkylTPP chain. Figure 2 shows the superoxide-quenching activity of MitoTEMPOL, the untargeted parent compound TEMPOL and CuZn-SOD in the cytochrome c superoxide assay. The rate of cytochrome c reduction by superoxide is significantly lowered by all three compounds while propylTPP, used as a control for the effect of TPP, has a negligible effect. The superoxide-quenching abilities of MitoTEMPOL and TEMPOL were comparable, suggesting that the addition of TPP to TEMPOL has little effect on its reactivity with superoxide. The reaction of MitoTEMPOL with superoxide was catalytic as, from EPR measurements, the concentration of MitoTEMPOL was unchanged over a 30 min reaction period (data not shown). In contrast to MitoTEMPOL, the hydroxylamine, MitoTEMPOL-H, had no measurable SOD-mimetic activity (data not shown).

Figure 2.

Figure 2

Open in a new tab

Superoxide dismutase activity of MitoTEMPOL. Superoxide was produced by mixing 20 mU xanthine oxidase with 10 mM acetaldehyde in 50 mM potassium phosphate buffer (pH 8) supplemented with 500 μg/ml ferricytochrome c at 37°C. The rate of cytochrome c reduction was followed at 550 nm for 60 s after which the appropriate amount of SOD, MitoTEMPOL, TEMPOL or propylTPP was added and the rate was followed for another 60 s. The slope of the cytochrome c reduction progress curve was measured after each addition and is expressed as a percentage of the slope before the addition. Results are means ± SD of three measurements. ** p < 0.01; § p < 0.05 with respect to the same concentration of MitoTEMPOL.

Reaction of MitoTEMPOL and MitoTEMPOL-H with ferrous/ferric ions

Cyclic nitroxides may also act as antioxidants by oxidizing cuprous and ferrous ions, thereby preventing oxidative damage resulting from the Fenton reaction. Figure 3A shows that MitoTEMPOL rapidly oxidizes the ferrous-EDTA complex, while the control compound, propylTPP, has no effect. To assess the reverse reaction of MitoTEMPOL-H with ferric-EDTA we measured the nitroxide concentration by EPR (Figure 3B). This experiment shows that there is some oxidation of MitoTEMPOL-H by ferric ions to form MitoTEMPOL and presumably ferrous iron. Thus, any antioxidant effects of MitoTEMPOL-H are not a result of modifying the Fenton reaction.

Figure 3.

Figure 3

Open in a new tab

Interactions of MitoTEMPOL and MitoTEMPOL-H with iron. (A) MitoTEMPOL oxidizes ferrous iron. To a solution of EDTA (100 μM) was added 100 μM freshly prepared FeCl2 and a solution of a nitroxide or propylTPP as a control. The reaction mixture was kept anaerobic under a stream of argon. Samples (100 μl) were taken at specified intervals, immediately mixed with 1 mM Ferrozine (900 μl) and the concentration of the resulting complex measured spectrophotometrically at 562 nm. Results are means ± SD of three experiments. (B) MitoTEMPOL-H reduces ferric ions. MitoTEMPOL-H (6 μM) was mixed with 100 μM ferric EDTA in anaerobic (N2-purged) 50 mM Tris-Cl buffer (pH 7). The concentration of MitoTEMPOL was measured by EPR. The nitroxide signal in the ‘no addition’ samples is due to background oxidation of the hydroxylamine. Results are means ± SD of three experiments.

Prevention of lipid peroxidation by MitoTEMPOL and MitoTEMPOL-H

In addition to catalysing superoxide dismutation and oxidizing ferrous and cuprous ions, piperidine nitroxides can react directly with a variety of free radicals and detoxify them. Therefore we tested the ability of MitoTEMPOL to prevent lipid peroxidation. To do this we used small unilamellar phospholipid vesicles (SUVs) incorporating the fluorescent peroxidation probe C11-BODIPY, and initiated lipid peroxidation by addition of the free radical generator 2,2′-azobis(2-amidinopropane) (AAPH) (Figure 4). The fluorescence of C11-BODIPY declined over time after addition of AAPH consistent with lipid peroxidation (Figure 4A). While MitoTEMPOL slowed this peroxidation, the hydroxylamine form, MitoTEMPOL-H, was far more protective. This is particularly evident in the data in the bar chart (Figure 4B) obtained from repeated experiments. Next, we compared the protective effect against lipid peroxidation of MitoTEMPOL-H with that of another mitochondria-targeted antioxidant, the ubiquinol (MitoQH2) form of MitoQ (Figure 4C and D). These data show that MitoTEMPOL-H is similar in efficacy to MitoQH2, which is well established to be effective at decreasing lipid peroxidation in a number of systems and to prevent mitochondrial oxidative damage in vivo [28,42].

Figure 4.

Figure 4

Open in a new tab

Antioxidant reactions of MitoTEMPOL. (A and B) MitoTEMPOL and MitoTEMPOL-H prevent lipid peroxidation in phospholipid vesicles. Small univesicular phosphatidylcholine vesicles (SUVs) (1 mg/ml) were suspended in 50 mM Tris-Cl buffer (pH 7) and pre-incubated for 10 min with 200 nM C11-BODIPY and either vehicle, 100 μM MitoTEMPOL or 100 μM MitoTEMPOL-H at 38°C. To this mixture AAPH (25 mM) was added and the changes in fluorescence were followed at λEx = 540 nm, λEm = 590 nm. (A) Typical traces. (B) Fluorescence at various times as a percentage of time zero: data are means ± SD of three experiments. (C and D) Comparison of the antioxidant activities of MitoTEMPOL-H and reduced MitoQ (MitoQH2). Experimental conditions are as described for panels A and B: * p<0.05; ** p<0.01 vs time zero. (E) MitoTEMPOL, MitoTEMPOL-H and TEMPOL prevent TBARS formation in mitochondrial membranes stressed with H2O2. Bovine heart mitochondrial membranes (1 mg protein) were suspended in 800 μl of 50 mM potassium phosphate buffer (pH 8) supplemented with 25 mM glucose and were incubated with 1 U/ml glucose oxidase for 30 min at 37°C. TBARS were measured relative to a malondialdehyde (MDA) standard curve as described in Materials and methods. Data are means ± SD of three experiments ** p<0.01. (F) MitoTEMPOL prevents TBARS formation in rat liver mitochondria stressed with ferrous iron. Mitochondria (2 mg protein) were suspended in 800 μl Tris-buffered KCl medium (100 mM KCl, 10 mM Tris-Cl, pH 7.6) supplemented with 10 mM glutamate/malate and incubated with 10 μM FeCl2±1 μM MitoTEMPOL or propylTPP for 30 min at 37°C. TBARS were measured as described in Materials and methods. Results are means±SD of three experiments. ** p<0.01, NS, not significant.

To determine if MitoTEMPOL and MitoTEMPOL-H decrease lipid peroxidation in more biologically relevant systems, we investigated bovine heart mitochondrial membranes exposed to hydrogen peroxide and measured thiobarbituric acid-reactive species (TBARS) as a marker of lipid peroxidation (Figure 4E). Both TEMPOL and MitoTEMPOL prevented lipid peroxidation, but MitoTEMPOL is significantly more effective, probably due to its higher affinity to phospholipids bilayers [18]. Consistent with the findings from the C11-BODIPY assay, MitoTEMPOL-H is also a more effective antioxidant against lipid peroxidation than MitoTEMPOL in this system. Finally, we assessed the ability of MitoTEMPOL to prevent lipid peroxidation in intact, energized mitochondria exposed to ferrous iron to induce lipid peroxidation, measured by the TBARS assay (Figure 4F). MitoTEMPOL (1 μM) significantly reduced lipid peroxidation, while the TPP control compound was ineffective (Figure 4F). As MitoTEMPOL is very rapidly and completely converted to MitoTEMPOLH within energized mitochondria [18], this protection is ascribed to MitoTEMPOL-H and demonstrates that MitoTEMPOL-H is an effective antioxidant within mitochondria.

Antioxidant mechanism of MitoTEMPOL-H

The most likely mechanism by which MitoTEMPOL-H could act as an antioxidant is through the chain-breaking donation of a hydrogen atom to a lipid-derived or other radical [24], thereby producing the nitroxide radical (MitoTEMPOL). To see if this occurred we reacted MitoTEMPOL-H with radicals generated by AAPH. Under these conditions the concentration of the nitroxide MitoTEMPOL increased over time significantly faster than by simple auto-oxidation in the absence of AAPH (Figure 5). Therefore MitoTEMPOL-H can react with radicals to produce the nitroxide MitoTEMPOL, which in vivo would be rapidly recycled to the hydroxylamine by ubiquinol within mitochondria [18].

Figure 5.

Figure 5

Open in a new tab

The reaction of MitoTEMPOL-H with radicals produces MitoTEMPOL. MitoTEMPOL-H (1 mM) was incubated± AAPH (1 mM) in 50 mM Tris buffer (pH 7) at 80°C, samples were taken at given time points and the intensity of the nitroxide signal was measured by EPR. Results are means±SD of three experiments.

Mitochondrial protection by MitoTEMPOL in cells

We have established a plausible antioxidant model of action of MitoTEMPOL within cells whereby it will be taken up selectively into mitochondria and there converted to MitoTEMPOL-H, selectively protecting mitochondria from oxidative damage [18]. To see if this was the case, we investigated whether MitoTEMPOL protected against oxidative damage to mitochondrial DNA (mtDNA). Oxidative damage was induced by using the redox cycler menadione, which is known to generate superoxide within mitochondria that can lead to lipid oxidation, as well as to a number of other types of oxidative damage such as lipid peroxidation, all of which can damage mtDNA [43,44]. A quantitative PCR (QPCR) assay was utilized to measure oxidative damage to mtDNA by comparing the relative amplification of a short and a very long segment of mtDNA. Any decrease in relative amplification of the long segment was due to DNA damage and therefore an indication of general oxidative damage to the mtDNA. A further advantage of this procedure is that there is no need to isolate mitochondria or to separate mtDNA from nuclear DNA, thereby avoiding artefacts caused by differential recovery of mitochondria or mtDNA following damage.

The relative amplification of mtDNA decreased in cells that were oxidatively stressed by menadione due to mtDNA damage (Figure 6A). The presence of MitoTEMPOL decreases this damage to mtDNA (Figure 6A). The same concentration of the untargeted nitroxide TEMPOL is significantly less effective than MitoTEMPOL at preventing mtDNA damage (Figure 6B). The TPP compound propylTPP, which lacks the nitroxide moiety, exhibits no protective effect, indicating that the protection is not due to the non-specific uptake of TPP compounds into mitochondria (Figure 6C). These results indicate that MitoTEMPOL can selectively protect mitochondria in cells from oxidative damage and this effect requires both the nitroxide moiety and the targeting into mitochondria.

Figure 6.

Figure 6

Open in a new tab

MitoTEMPOL protects mitochondrial DNA from damage by menadione. (A–C) C2C12 cells were seeded in 6-well plates at 300 000 cells/well and left to attach overnight in medium. They were then pre-incubated for 1 h with medium containing 50 μM MitoTEMPOL or propylTPP after which 25 μM menadione was added and cells were incubated for a further 1 h at 37°C. Cells were then harvested by scraping, the DNA was isolated and amplified by QPCR and the product quantified using PicoGreen. Results are means±SEM of three experiments. * p<0.05; ** p<0.01, NS, non-significant.

Discussion

Here we have shown that the mitochondria-targeted antioxidant MitoTEMPOL has similar in vitro antioxidant efficacy to its precursor TEMPOL, indicating that conjugation to TPP does not interfere with the antioxidant activity of TEMPOL. Previously we have shown that MitoTEMPOL is very rapidly converted to the hydroxylamine MitoTEMPOL-H by ubiquinol in mitochondria and cells [18]. Therefore, it is unlikely that there will be any MitoTEMPOL present in a biological situation and that the dominant compound will be MitoTEMPOL-H. The antioxidant efficacy of MitoTEMPOL-H was quite different from that of MitoTEMPOL, as it had no SOD-mimetic activity nor could it oxidize ferrous iron. However, MitoTEMPOL-H was a very effective chain-breaking antioxidant, preventing lipid peroxidation. This reaction was shown to occur by the transfer of a hydrogen atom from MitoTEMPOL-H to quench a radical. While this reaction generates MitoTEMPOL, in mitochondria this nitroxide would be rapidly converted back to MitoTEMPOL-H. Therefore, a plausible mode for the antioxidant activity of MitoTEMPOL in mitochondria and cells is that it is rapidly converted to MitoTEMPOL-H within mitochondria and acts as a chain breaking antioxidant against free radicals by donating a hydrogen atom. In doing so, it is converted to the nitroxide MitoTEMPOL, which is then rapidly recycled back to MitoTEMPOL-H by mitochondrial ubiquinol. Thus, MitoTEMPOL may be an effective antioxidant as it is capable of being rapidly recycled within mitochondria by the respiratory chain, in a similar manner to MitoQ [34,42].

Consequently, even though MitoTEMPOL is rapidly converted to MitoTEMPOL-H this should still lead to effective antioxidant protection against mitochondrial damage. This is because MitoTEMPOL-H is a good antioxidant, it is accumulated by mitochondria, will be rapidly recycled by ubiquinol in mitochondria and has a strong affinity for the surface of phospholipid bilayers, where most oxidative damage occurs within mitochondria. This was confirmed within cells, where MitoTEMPOL was shown to be protective against mitochondrial oxidative damage to mtDNA caused by the redox cycler menadione. Therefore, targeting a piperidine nitroxide to mitochondria is an effective antioxidant strategy, even if the nitroxide is rapidly converted to its hydroxyla-mine, and our results suggest that the efficacy of mitochondria-targeted TEMPOL should be assessed in a range of other systems, where mitochondria-targeted antioxidants such as MitoQ have been shown to be effective. In addition, these findings suggest that some of the antioxidant efficacy of TEMPOL in vivo may be due to its hydroxyalmine.

Acknowledgments

This work was supported by the Medical Research Council, the Gates Cambridge Trust and the Research Committee of the University of Otago.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Abbreviations

AAPH

2,2′-azobis(2-amidinopropane)

BHM

bovine heart mitochondrial membranes

BSA

bovine serum albumin

MitoTEMPOL

2,2,6,6-tetramethyl-4-[5-(triphenylphosphonio)pentoxy]piperidin-1-oxy bromide

MitoTEMPOL-H

hydroxylamine of MitoTEMPOL

MitoQ

[10-(4,5-dimethoxy-2-methyl-3,6-dioxo-1, 4-cyclohexadien-1-yl)decyl]triphenylphosphonium methanesulphonate

MitoQH2

[10-(3,6-dihydroxy-4,5-dimethoxy-2-methylphenyl)decyl]triphenylphosphonium

MDA

malondialdehyde

mtDNA

mitochondrial DNA

PBS

phosphate-buffered saline

QPCR

quantitative PCR

ROS

reactive oxygen species

SOD

superoxide dismutase

SUV

small unilamellar phosphatidylcholine vesicles

TBARS

thiobarbituric acid-reactive species

TEMPOL

4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxy radical

TPP

triphenylphosphonium moiety

References

  • 1.Mitchell JB, Samuni A, Krishna MC, DeGraff WG, Ahn MS, Samuni U, Russo A. Biologically active metal-independent superoxide dismutase mimics. Biochemistry. 1990;29:2802–2807. doi: 10.1021/bi00463a024. [DOI] [PubMed] [Google Scholar]
  • 2.Samuni A, Godinger D, Aronovitch J, Russo A, Mitchell JB. Nitroxides block DNA scission and protect cells from oxidative damage. Biochemistry. 1991;30:555–561. doi: 10.1021/bi00216a033. [DOI] [PubMed] [Google Scholar]
  • 3.Samuni AM, DeGraff W, Krishna MC, Mitchell JB. Cellular sites of H2O2-induced damage and their protection by nitroxides. Biochim Biophys Acta. 2001;1525:70–76. doi: 10.1016/s0304-4165(00)00172-0. [DOI] [PubMed] [Google Scholar]
  • 4.Miura Y, Utsumi H, Hamada A. Antioxidant activity of nitroxide radicals in lipid peroxidation of rat liver microsomes. Arch Biochem Biophys. 1993;300:148–156. doi: 10.1006/abbi.1993.1021. [DOI] [PubMed] [Google Scholar]
  • 5.Liang Q, Smith AD, Pan S, Tyurin VA, Kagan VE, Hastings TG, Schor NF. Neuroprotective effects of TEMPOL in central and peripheral nervous system models of Parkinson's disease. Biochem Pharmacol. 2005;70:1371–1381. doi: 10.1016/j.bcp.2005.04.011. [DOI] [PubMed] [Google Scholar]
  • 6.McDonald MC, Zacharowski K, Bowes J, Cuzzocrea S, Thiemermann C. Tempol reduces infarct size in rodent models of regional myocardial ischemia and reperfusion. Free Radic Biol Med. 1999;27:493–503. doi: 10.1016/s0891-5849(99)00100-8. [DOI] [PubMed] [Google Scholar]
  • 7.Mitchell JB, Xavier S, DeLuca AM, Sowers AL, Cook JA, Krishna MC, Hahn SM, Russo A. A low molecular weight antioxidant decreases weight and lowers tumor incidence. Free Radic Biol Med. 2003;34:93–102. doi: 10.1016/s0891-5849(02)01193-0. [DOI] [PubMed] [Google Scholar]
  • 8.Schubert R, Erker L, Barlow C, Yakushiji H, Larson D, Russo A, Mitchell JB, Wynshaw-Boris A. Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice. Hum Mol Genet. 2004;13:1793–1802. doi: 10.1093/hmg/ddh189. [DOI] [PubMed] [Google Scholar]
  • 9.Samuni AM, Barenholz Y, Crommelin DJ, Zuidam NJ. Gamma-irradiation damage to liposomes differing in composition and their protection by nitroxides. Free Radic Biol Med. 1997;23:972–979. doi: 10.1016/s0891-5849(97)00123-8. [DOI] [PubMed] [Google Scholar]
  • 10.Samuni A, Krishna CM, Riesz P, Finkelstein E, Russo A. A novel metal-free low molecular weight superoxide dismutase mimic. J Biol Chem. 1988;263:17921–17924. [PubMed] [Google Scholar]
  • 11.Samuni A, Krishna CM, Mitchell JB, Collins CR, Russo A. Superoxide reaction with nitroxides. Free Radic Res Commun. 1990;9:241–249. doi: 10.3109/10715769009145682. [DOI] [PubMed] [Google Scholar]
  • 12.Bar-On P, Mohsen M, Zhang R, Feigin E, Chevion M, Samuni A. Kinetics of nitroxide reaction with iron(II) J Am Chem Soc. 1999;121:8070–8073. [Google Scholar]
  • 13.Krishna MC, Samuni A, Taira J, Goldstein S, Mitchell JB, Russo A. Stimulation by nitroxides of catalase-like activity of hemeproteins. Kinetics and mechanism. J Biol Chem. 1996;271:26018–26025. doi: 10.1074/jbc.271.42.26018. [DOI] [PubMed] [Google Scholar]
  • 14.Mehlhorn RJ, Swanson CE. Nitroxide-stimulated H2O2 decomposition by peroxidases and pseudoperoxidases. Free Radic Res Commun. 1992;17:157–175. doi: 10.3109/10715769209068163. [DOI] [PubMed] [Google Scholar]
  • 15.Samuni A, Goldstein S, Russo A, Mitchell JB, Krishna MC, Neta P. Kinetics and mechanism of hydroxyl radical and OH-adduct radical reactions with nitroxides and with their hydroxylamines. J Am Chem Soc. 2002;124:8719–8724. doi: 10.1021/ja017587h. [DOI] [PubMed] [Google Scholar]
  • 16.Goldstein S, Samuni A. Kinetics and mechanism of peroxyl radical reactions with nitroxides. J Phys Chem A. 2007;111:1066–1072. doi: 10.1021/jp0655975. [DOI] [PubMed] [Google Scholar]
  • 17.Andreyev AY, Kushnareva YE, Starkov AA. Mitochondrial metabolism of reactive oxygen species. Biochemistry (Mosc) 2005;70:200–214. doi: 10.1007/s10541-005-0102-7. [DOI] [PubMed] [Google Scholar]
  • 18.Trnka J, Blaikie FH, Smith RA, Murphy MP. A mitochondria-targeted nitroxide is reduced to its hydroxylamine by ubiquinol in mitochondria. Free Radic Biol Med. 2008;44:1406–1419. doi: 10.1016/j.freeradbiomed.2007.12.036. [DOI] [PubMed] [Google Scholar]
  • 19.Ross MF, Prime TA, Abakumova I, James AM, Porteous CM, Smith RA, Murphy MP. Rapid and extensive uptake and activation of hydrophobic triphenylphosphonium cations within cells. Biochem J. 2008;411:633–645. doi: 10.1042/BJ20080063. [DOI] [PubMed] [Google Scholar]
  • 20.Murphy MP, Smith RA. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol. 2007;47:629–656. doi: 10.1146/annurev.pharmtox.47.120505.105110. [DOI] [PubMed] [Google Scholar]
  • 21.Quintanilha AT, Packer L. Surface localization of sites of reduction of nitroxide spin-labeled molecules in mitochondria. Proc Natl Acad Sci USA. 1977;74:570–574. doi: 10.1073/pnas.74.2.570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Chen K, Morse PD, 2nd, Swartz HM. Kinetics of enzyme-mediated reduction of lipid soluble nitroxide spin labels by living cells. Biochim Biophys Acta. 1988;943:477–484. doi: 10.1016/0005-2736(88)90380-x. [DOI] [PubMed] [Google Scholar]
  • 23.Xavier S, Yamada K, Samuni AM, Samuni A, DeGraff W, Krishna MC, Mitchell JB. Differential protection by nitr-oxides and hydroxylamines to radiation-induced and metal ion-catalyzed oxidative damage. Biochim Biophys Acta. 2002;1573:109–120. doi: 10.1016/s0304-4165(02)00339-2. [DOI] [PubMed] [Google Scholar]
  • 24.Zhang R, Pinson A, Samuni A. Both hydroxylamine and nitroxide protect cardiomyocytes from oxidative stress. Free Radic Biol Med. 1998;24:66–75. doi: 10.1016/s0891-5849(97)00165-2. [DOI] [PubMed] [Google Scholar]
  • 25.Zigler JS, Jr, Qin C, Kamiya T, Krishna MC, Cheng Q, Tumminia S, Russell P. Tempol-H inhibits opacification of lenses in organ culture. Free Radic Biol Med. 2003;35:1194–1202. doi: 10.1016/s0891-5849(03)00505-7. [DOI] [PubMed] [Google Scholar]
  • 26.Atamna H, Paler-Martinez A, Ames BN. N-t-butyl hydro-xylamine, a hydrolysis product of alpha-phenyl-N-t-butyl nitrone, is more potent in delaying senescence in human lung fibroblasts. J Biol Chem. 2000;275:6741–6748. doi: 10.1074/jbc.275.10.6741. [DOI] [PubMed] [Google Scholar]
  • 27.Lee JH, Kim IS, Park JW. The use of N-t-butyl hydroxyla-mine for radioprotection in cultured cells and mice. Carcinogenesis. 2004;25:1435–1442. doi: 10.1093/carcin/bgh139. [DOI] [PubMed] [Google Scholar]
  • 28.Kelso GF, Porteous CM, Coulter CV, Hughes G, Porteous WK, Ledgerwood EC, Smith RA, Murphy MP. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem. 2001;276:4588–4596. doi: 10.1074/jbc.M009093200. [DOI] [PubMed] [Google Scholar]
  • 29.Henry-Riyad H, Tidwell TT. Cyclization of 5-hexenyl radicals from nitroxyl radical additions to 4-pentenylketenes and from the acyloin reaction. Can J Chem. 2003;81:697–704. [Google Scholar]
  • 30.Chappell JB, Hansford RG. Preparation of mitochondria from animal tissues and yeasts. In: Birnie GD, editor. Subcellular components: Preparation and fractionation. London: Butterworths; 1972. pp. 77–91. [Google Scholar]
  • 31.Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J Biol Chem. 1949;177:751–766. [PubMed] [Google Scholar]
  • 32.Smith AL. Preparation, properties, and condition for assay of mitochondria: slaughterhouse material, small-scale. Methods Enzymol. 1967;10:81–86. [Google Scholar]
  • 33.Walker JE, Skehel JM, Buchanan SK. Structural analysis of NADH: ubiquinone oxidoreductase from bovine heart mitochondria. Methods Enzymol. 1995;260:14–34. doi: 10.1016/0076-6879(95)60127-9. [DOI] [PubMed] [Google Scholar]
  • 34.James AM, Sharpley MS, Manas AR, Frerman FE, Hirst J, Smith RA, Murphy MP. Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases. J Biol Chem. 2007;282:14708–14718. doi: 10.1074/jbc.M611463200. [DOI] [PubMed] [Google Scholar]
  • 35.Carter P. Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine) Anal Biochem. 1971;40:450–458. doi: 10.1016/0003-2697(71)90405-2. [DOI] [PubMed] [Google Scholar]
  • 36.Gibbs C. Characeterization and application of FerroZine iron reagent as a ferrous iron reagent. Anal Biochem. 1976;48:1197–1201. [Google Scholar]
  • 37.Atlante A, Valenti D, Gagliardi S, Passarella S. A sensitive method to assay the xanthine oxidase activity in primary cultures of cerebellar granule cells. Brain Res Brain Res Protoc. 2000;6:1–5. doi: 10.1016/s1385-299x(00)00030-1. [DOI] [PubMed] [Google Scholar]
  • 38.Pap EH, Drummen GP, Winter VJ, Kooij TW, Rijken P, Wirtz KW, Op den Kamp JA, Hage WJ, Post JA. Ratio-fluorescence microscopy of lipid oxidation in living cells using C11-BODIPY(581/591) FEBS Lett. 1999;453:278–282. doi: 10.1016/s0014-5793(99)00696-1. [DOI] [PubMed] [Google Scholar]
  • 39.Wilbur KM, Bernheim F, Shapiro OW. The thiobarbituric acid reagent as a test for the oxidation of unsaturated fatty acids by various agents. Arch Biochem. 1949;24:305–313. [PubMed] [Google Scholar]
  • 40.Couet WR, Brasch RC, Sosnovsky G, Tozer TN. Factors affecting nitroxide reduction in ascorbate solution and tissue homogenates. Magn Reson Imaging. 1985;3:83–88. doi: 10.1016/0730-725x(85)90012-8. [DOI] [PubMed] [Google Scholar]
  • 41.Santos JH, Meyer JN, Mandavilli BS, Van Houten B. Quantitative PCR-based measurement of nuclear and mitochondrial DNA damage and repair in mammalian cells. Methods Mol Biol. 2006;314:183–199. doi: 10.1385/1-59259-973-7:183. [DOI] [PubMed] [Google Scholar]
  • 42.James AM, Cochemé HM, Smith RA, Murphy MP. Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools. J Biol Chem. 2005;280:21295–21312. doi: 10.1074/jbc.M501527200. [DOI] [PubMed] [Google Scholar]
  • 43.Hollensworth SB, Shen C, Sim JE, Spitz DR, Wilson GL, LeDoux SP. Glial cell type-specific responses to menadione-induced oxidative stress. Free Radic Biol Med. 2000;28:1161–1174. doi: 10.1016/s0891-5849(00)00214-8. [DOI] [PubMed] [Google Scholar]
  • 44.Grishko V, Solomon M, Wilson GL, LeDoux SP, Gillespie MN. Oxygen radical-induced mitochondrial DNA damage and repair in pulmonary vascular endothelial cell phenotypes. Am J Physiol Lung Cell Mol Physiol. 2001;280:L1300–1308. doi: 10.1152/ajplung.2001.280.6.L1300. [DOI] [PubMed] [Google Scholar]

Articles from Free Radical Research are provided here courtesy of Taylor & Francis

RESOURCES